Article Per Year (5 Year)
p-Index From 2021 - 2026
0.23
P-Index
This Author published in this journals
All Journal Jurnal Insan Farmasi Indonesia
Tia Yulianti
Fakultas Ilmu Komunikasi
Biochemistry, Genetics & Molecular Biology Chemistry Immunology & microbiology Medicine & Pharmacology Physics

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

 1 
ANALISIS INTERAKSI OBAT PADA PASIEN DISPEPSIA DENGAN PENYAKIT PENYERTA DI INSTALASI RAWAT INAP DI RUMAH SAKIT X KABUPATEN MAJALENGKA TAHUN  2024 Yulianti, Tia; Ade Irawan; Putra, Teguh Adiyas
Jurnal Insan Farmasi Indonesia Vol 8 No 2 (2025): Jurnal Insan Farmasi Indonesia
Publisher : Sekolah Tinggi Ilmu Kesehatan ISFI Banjarmasin

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.36387/weamq732

Abstract

Dyspepsia is common digestive disorder that can significantly impact a patient's quality of life, particularly in individuals with comorbid conditions. Lifestyle factors, stress, and the use of various medications can contribute the onset of symptoms. One important aspect to consider is drug interactions, especially in elderly patients undergoing polypharmacy. This study aims to analyze drug usage patterns and identify potential drug interactions in patients diagnosed with dyspepsia and comorbidities. The research employed a non-experimental observational design using a retrospective descriptive method. Data were collected from inpatient medical records at Hospital X in Majalengka Regency, involving patients diagnosed with dyspepsia and accompanying illnesses. The profile dyspepsia patients with comorbidities in the inpatient unit of Majalengka Regional Hospital in 2024 was: the highest number patients were aged 46-55 years (24 patients, or 29%), and the highest number of patients were female (63 patients, or 78%). The most common single drug used for dyspepsia was ranitidine (14 cases, 87.50%). The most common two-drug combination was ranitidine and sucralfate (9 cases, 25.00%), and the most common three-drug combination was sucralfate + ranitidine + domperidone (12 cases, 37.50%). Drug interactions, based on severity, were classified as minor (32 cases, 96.97%), and moderate (1 case, 3.03%).
Co-Authors Ade Irawan Putra, Teguh Adiyas